A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...
1 As new weight-loss medications become available, can they really reverse the upward trend for chronic diseases, which costs lives and money? Used to treat type 2 diabetes, glucagon-like peptide-1 ...
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
Credit: Getty Images Experts weigh in on the ramifications of GLP-1 drug shortages and how they affect patients who need these medications for the management of diabetes. With the ongoing surge in ...
aNottingham Digestive Diseases Centre (NDDC), Translational Medical Sciences, School of Medicine, University of Nottingham, NG7 2UH, UK bNIHR Nottingham Biomedical Research Centre, Nottingham ...
We are pleased to complete the last subject visit in our Phase 1 trial of MBX 1416 in healthy adults and extend our sincere appreciation to the participants, investigators and clinical team for their ...